Recent News
Nintedanib May Surpass Bevacizumab as a More Effective Chemotherapy Treatment for Mesothelioma
In 2016, scientists and researchers were excited to begin Phase II of the clinical trial involving treating patients with malignant pleural mesothelioma with Nintedanib, a triple angiokinase inhibitor designed to[…]
EPA Proposes New Rules For Asbestos; Anti-Asbestos Advocates Concerned
In June 2016, former President Obama signed the Frank R. Lautenberg Chemical Safety for the 21st Century Act as an amendment to the Toxic Substances Control Act (TSCA), and since[…]
Updated Modified RECIST to Better Evaluate Treatment Response in Mesothelioma
The Response Evaluation Criteria in Solid Tumors (RECIST) was established nearly two decades ago by the European Organization for Research and Treatment of Cancer and the National Cancer Institute of[…]
Immunotherapy – What Side Effects Can You Expect?
As the success of immunotherapy treatments in improving survival and symptom management for cancer patients have started to become known, those suffering from cancer such as mesothelioma and lung cancer[…]
Techniques for Determining a Mesothelioma Diagnosis
If you have been exposed to asbestos and are exhibiting symptoms of mesothelioma including: pain in the side of your chest and lower back, shortness of breath, cough, fever, excessive[…]
ONCOS-102 Update: Mesothelioma Patients Responded after Phase II Clinical Trial
Advancement in mesothelioma treatments over the past decade has been relativity stagnant, according to Targovax – a Norwegian immune-cology company dedicated to the study and research of immunotherapy treatments. However,[…]
Safer and Less Intrusive Lung Cancer Test
In order to test for cancer, people have to go through invasive and even risky procedures to remove and biopsy a tumor. With these risky procedures between 75 and 85[…]
Aerosol Chemotherapy – Targeting Peritoneal Mesothelioma Through Pressurized Medicine
Peritoneal mesothelioma is an incredibly rare form of cancer that affects the peritoneum, or abdominal lining. It is not entirely understood how exposure to asbestos causes this type of cancer,[…]
New Surgical Technique Could Be Ideal for Patients with Advanced Pleural Mesothelioma
Pleural mesothelioma is a rare and aggressive cancer that has been notoriously difficult to treat. Caused by asbestos exposure, the latency period between the time of initial exposure and disease[…]
Immunotherapy May Help Extend the Lives of Lung Cancer and Mesothelioma Patients
Immunotherapy is revolutionizing the health care industry by adding extra years of life to people with lung cancer. A few years ago it was rare for patients with an advanced[…]
Skip to content